In this paper, we present evidence that the β-catenin-TCF4 complex increases the expression of CEGRs/ALCDs-dependent oncogenes in HBL patients, HBL cell lines, and PDX mouse models of HBL. Here, TCF4 is linked to hepatoblastoma.